Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: shero who wrote (3133)	6/3/1999 9:38:00 PM
From: Bob L	Read Replies (2) \| Respond to of 3702

There are three ways to get treated with an experimental drug. 1. Enroll in a clinical trial if you are eligible. 2. Participate in a Treatment IND ("Treatment with an Investigational New Drug", aka "compassionate use") program initiated by the drug company and approved by the FDA. This is how Genentech made Herceptin available to many patients outside their trial, but before final FDA approval of the drug. 3. Apply to FDA for individual approval for treatment IND. An individual patient can seek approval for treatment for just himself or herself, theoretically. I was asking if you happened to know whether TCLN had assisted patients under option 3.